Xeomin (botulinum neurotoxin type A) for treating chronic sialorrhoea
Technology appraisal guidance
Reference number: TA605
Published:
Please note that following on from information provided by the company the timelines for this appraisal have been revised and the appraisal is now anticipated to begin in late November 2018.